Gene Symbol | RELB |
---|---|
Entrez Gene | 5971 |
Alt Symbol | I-REL, IREL, REL-B |
Species | Human |
Gene Type | protein-coding |
Description | v-rel avian reticuloendotheliosis viral oncogene homolog B |
Other Description | transcription factor RelB|v-rel avian reticuloendotheliosis viral oncogene homolog B (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3)|v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 |
Swissprots | Q6GTX7 Q9UEI7 Q01201 |
Accessions | AAC82346 ABC40746 EAW57316 Q01201 AK290594 BAF83283 AL583128 AW137991 BC028013 AAH28013 BI906507 BM684710 DA940587 M83221 AAA36127 XM_005259127 XP_005259184 XM_005259128 XP_005259185 NM_006509 NP_006500 |
Function | NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF- kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF- kappa-B inhibitor (I-kappa- |
Subcellular Location | Nucleus {ECO:0000269|PubMed:20873783}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:20873783}. Note=Colocalizes with NEK6 in the centrosome. |
Top Pathways | MAPK signaling pathway, Osteoclast differentiation, HTLV-I infection, Epstein-Barr virus infection |
Human Rel B full length protein - ab152653 from Abcam
|
||||||||||
Human Rel B full length protein - ab84654 from Abcam
|
||||||||||
RELB Antibody Blocking Peptide - LS-E10839 from LifeSpan Bioscience
|
||||||||||
RELB Antibody Blocking Peptide - LS-E16039 from LifeSpan Bioscience
|
||||||||||
RELB Antibody Blocking Peptide - LS-E13255 from LifeSpan Bioscience
|
||||||||||
RELB Antibody Blocking Peptide - LS-E13256 from LifeSpan Bioscience
|
||||||||||
RELB Antibody Blocking Peptide - LS-E13979 from LifeSpan Bioscience
|
||||||||||
RELB Antibody Blocking Peptide - LS-E13978 from LifeSpan Bioscience
|
||||||||||
RELB Antibody Blocking Peptide - LS-E13588 from LifeSpan Bioscience
|
||||||||||
RelB Recombinant Protein - H00005971-P01 from Novus Biologicals
|
||||||||||
RELB Protein Lysate (APL10324) - APL10324 from Aviva Systems Biology
|
||||||||||
RELB Protein Lysate (APL10325) - APL10325 from Aviva Systems Biology
|
||||||||||
RELB Blocking Peptide - 33R-3469 from Fitzgerald
|
||||||||||
RELB Blocking Peptide - 33R-6307 from Fitzgerald
|
||||||||||
RELB Blocking Peptide - 33R-2979 from Fitzgerald
|
||||||||||
Human RELB Protein - abx069697 from Abbexa
|
||||||||||
RELB / I-Rel - H00005971-P01-10 from Acris Antibodies
|
||||||||||
RELB / I-Rel - H00005971-P01-25 from Acris Antibodies
|
||||||||||
V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB), Human - 20-8062 from ARP American Research Products
|
||||||||||
RELB fusion protein - ag13824 from Proteintech Group
|
||||||||||
RelB (Phospho-Ser552) Antibody Blocking Peptide - GWB-C321F6 from Genway Biotech
|
||||||||||
Recombinant Human RELB, His-tagged - RELB-1487H from Creative Biomart
|
||||||||||
Recombinant Human RELB, His-tagged - RELB-30492TH from Creative Biomart
|
||||||||||
Recombinant V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) - RPB826Hu01 from Uscn Life Science Inc.
|
||||||||||
Recombinant V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) - RPB826Mu01 from Uscn Life Science Inc.
|